These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7563585)

  • 61. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
    Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). II. Background of patients].
    Kumamoto Y; Tsukamoto T; Murai M; Matsukawa M; Kunishima Y; Watanabe K; Kobayashi Y; Uchida H; Hirose T; Shigeta S; Matsuda S; Sato S; Yamaguti O; Ogihara M; Ishibashi K; Fujime M; Fujita K; Takahashi K; Igari J; Yoshida H; Imafuku Y; Oguri T; Yamaguchi K; Furuya N; Fukuhara Y; Kashitani F; Kumon H; Monden K; Ooe H; Nishikawa M; Kohno S; Tomono K; Miyazaki Y; Oka T; Kitamura M; Hirakata Y; Aoki S; Matsuoka Y
    Jpn J Antibiot; 2003 Oct; 56(5):424-36. PubMed ID: 14692379
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
    Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). I. Susceptibility distribution].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):2959-3006. PubMed ID: 3102808
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
    Tiengrim S; Phiboonbanakit D; Thunyaharn S; Tantisiriwat W; Santiwatanakul S; Susaengrat W; Srisurat N; Malithong A; Srisangchan P; Thamlikitkul V
    J Med Assoc Thai; 2012 Feb; 95 Suppl 2():S6-17. PubMed ID: 22574524
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between April 1999 and March 2000].
    Mashita K; Shinagawa N; Manabe T; Takeyama H; Hasegawa M; Hirata K; Katsuramaki T; Mukaiya M; Ishikawa S; Ushijima Y; Mizuno A; Aikawa N; Kazuhiko S; Kinoshita H; Morimoto K; Iwai S; Kato K; Fujimoto M; Tanimura H; Sato T; Ohnishi H; Maeda T; Yura J; Tanaka N; Iwagaki H; Kimura H; Yokoyama T; Hiyama E; Fuchimoto S; Inoue F; Konaga E; Takeuchi H; Ikeda S; Yasunami Y; Sueda T; Takesue Y; Suzuki Y; Nakane Y
    Jpn J Antibiot; 2002 Dec; 55(6):697-729. PubMed ID: 12621728
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pathogenic bacteria of childhood lower respiratory tract infection].
    Hua CZ; Yu HM; Chen ZM; Li JP; Shang SQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):365-8. PubMed ID: 17052391
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Sensitivity of frequent-occurring isolates in outpatients to routinely-used antibiotics (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1979 Jun; 32(6):668-74. PubMed ID: 381708
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Antimicrobial activities of major oral antibacterial agents against clinically isolated microbial strains from inpatients].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y
    Jpn J Antibiot; 1992 Aug; 45(8):965-79. PubMed ID: 1433903
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Kadota J; Aoki N; Matsumoto T; Yoshida M; Yagisawa M; Oguri T; Sato J; Ogasawara K; Wakamura T; Sunakawa K; Watanabe A; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Watari T; Toyoshima E; Takeuchi K; Shiokoshi M; Takeda H; Miki M; Kumagai T; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Kobayashi N; Takasaki J; Mezaki K; Konosaki H; Aoki Y; Yamamoto Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Niki Y; Yoshida K; Kawana A; Saionji K; Fujikura Y; Miyazawa N; Kudo M; Sato Y; Yamamoto M; Yoshida T; Nakamura M; Tsukada H; Imai Y; Tsukada A; Kawasaki S; Honma Y; Yamamoto T; Ban N; Mikamo H; Sawamura H; Miyara T; Toda H; Sato K; Nakamura T; Fujikawa Y; Mitsuno N; Mikasa K; Kasahara K; Sano R; Sugimoto K; Asari S; Nishi I; Toyokawa M; Miyashita N; Koguchi Y; Kusano N; Mihara E; Kuwabara M; Watanabe Y; Kawasaki Y; Takeda K; Tokuyasu H; Masui K; Negayama K; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Suga M; Muranaka H; Morinaga Y; Honda J; Fujita M
    J Infect Chemother; 2015 Jun; 21(6):410-20. PubMed ID: 25817352
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [In vitro antibacterial activity of prulifloxacin, a new oral quinolone, and comparative susceptibility rate at clinical breakpoint MIC].
    Inoue M; Kuga A; Kaieda S; Hosaka M; Kitasato H; Sato Y; Okamoto R; Eda T; Hoshino K; Seto I
    Jpn J Antibiot; 2000 Sep; 53(9):593-608. PubMed ID: 11214999
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents. Special references to bacteria isolated between July 1994 and June 1995].
    Shinagawa N; Hirata K; Denno R; Mukaiya M; Ishibiki K; Ushijima Y; Aikawa N; Takuma K; Iwai S; Kunimatsu M; Ohtsuka K; Yura J; Manabe T; Mashita K; Ishikawa S; Mizuno A; Kinoshita H; Morimoto K; Fujimoto M; Tanimura H; Ohnishi H; Umemoto Y; Sakaguchi S; Dounishi H; Oda S
    Jpn J Antibiot; 1996 Sep; 49(9):849-91. PubMed ID: 8934288
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Analysis of distribution characteristics and drug resistance of 2748 strains of pathogens isolated from burn patients].
    Peng DZ; Liu XL; Liu ZY; Shu WT; Zhou X; Liu J; Huang YS; Wu J; Fu WL
    Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):87-95. PubMed ID: 22781318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
    Varotto F; Maria GD; Azzaro R; Bellissima P; Amato R; Fogliani V; Muscianisi G; Vitale S; Girbino G; Andò F; Laganà P; Delia S; Jacoviello C; Maierna G; Pezza A; Covelli I; Magrì M; Napoletano G; Rossi A; Marone P; Sanguinetti C; Pela R; Tedeschi D; Viola B; Cicciarella S; Messina G; Rizza S; Fraschini F
    J Chemother; 2001 Aug; 13(4):413-23. PubMed ID: 11589485
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Measurement of MICs on 16 antimicrobial agents for freshly isolated methicillin-resistant Staphylococcus aureus strains].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y
    Jpn J Antibiot; 1990 Apr; 43(4):623-35. PubMed ID: 2381034
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Antibacterial activities of piperacillin for several resistant strains from respiratory infections--in reference to MRSA, PRSP, BLNAR and P. aeruginosa].
    Matsuzaki K; Koyama H; Omika K; Hasegawa M; Sato Y; Kobayashi I; Watanabe A
    Jpn J Antibiot; 2000 Aug; 53(8):566-72. PubMed ID: 11070818
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1982)].
    Ikemoto H; Watanabe K; Kosakai N; Igari J; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S
    Jpn J Antibiot; 1984 Jul; 37(7):1241-62. PubMed ID: 6333525
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Mechanism of antibiotic resistance in bacteria responsible for respiratory infections].
    Dye D; Croize J; Brambilla C
    Rev Mal Respir; 1995; 12(5):415-27. PubMed ID: 8560072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.